Omega Healthcare Investors, Inc.

As of June 30, 2026, Omega Healthcare Investors, Inc. carries a market capitalization of 232.22B, placing it among publicly traded companies globally. Its enterprise value stands at 306.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Omega Healthcare Investors, Inc.'s next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Omega Healthcare Investors, Inc. has 299.11M shares outstanding.

As of June 30, 2026, Omega Healthcare Investors, Inc. trades at a trailing price-to-earnings ratio of 15.38. The price-to-sales ratio is 10.30, and the price-to-book ratio stands at 2.47.

As of June 30, 2026, Omega Healthcare Investors, Inc. trades at an EV/EBITDA multiple of 12.40 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 13.67 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 16.19 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Omega Healthcare Investors, Inc. trades at an EV/FCF ratio of 16.01, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 306.25B versus a market cap of 232.22B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Omega Healthcare Investors, Inc. maintains a current ratio of 5.93, meaning it holds 5.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 71.33, indicating elevated leverage, while an interest coverage ratio of 6.81 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. posted a return on equity (ROE) of 16.54, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.71 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.35, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.33, useful for judging operating efficiency across full business cycles. The company generates approximately 335.56M in revenue per employee across its workforce of 66.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. recorded 285.36M in income tax expense. That works out to an effective tax rate of 1.81, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 15.76B, leaving 15.00B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 13, 2026, Omega Healthcare Investors, Inc.'s stock has gained approximately 46.87% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. generated 22.40B in revenue and converted that into 15.00B in net income, yielding earnings per share of 49.94. EBITDA reached 24.70B, while operating income came in at 14.12B.

As of June 30, 2026, Omega Healthcare Investors, Inc. holds 682.02M in cash and equivalents against 70.32B in total debt, resulting in a net debt position of 69.63B. Total book value stands at 94.18B, with working capital of 30.46B providing operational flexibility.

Omega Healthcare Investors, Inc. produced 15.56B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. posted a gross margin of 97.42, reflecting its pricing power and cost economics. The operating margin of 63.04 and net profit margin of 66.96 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. paid dividends of 46.77 per share. The dividend payout ratio of 85.31 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.40, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 12.52, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Omega Healthcare Investors, Inc. shareholders.

As of June 30, 2026, Omega Healthcare Investors, Inc. has an Altman Z-Score of 1.94, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.